Aktis Oncology

Developer of radiopharmaceuticals for solid tumor cancers

placeBoston, Massachusetts, United States calendar_todayFounded 2021 groups15 employees language aktisoncology.com

Registered entities

Social engagement

Social engagement: 13.1K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include EcoR1, Vida Ventures, Novartis, Bristol-Myers Squibb; 1 has since exited.

Investor typeCountShare
Venture capital1056%
Bank & private debt211%
Other / undisclosed633%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

10 Mar 2026 · Director, Clinical Operations · Boston

Based on job postings tracked across public sources.

Recent activity

27 May 2026
Event
Jefferies Global Healthcare Conference
26 May 2026
Event
webcast on AKY-2519 clinical imaging and dosimetry data for B7-H3 expressing tumors
Coming soon